Biodegradable microparticles for strictly regulating the release of neurotrophic factors
Abstract
A lot of research has been carried out in the last decade to find a cure for neurodegenerative diseases especially Parkinson's disease but to little avail. In this study we have demonstrated the use of poly(lactic-co-glycolic acid) (PLGA)/collagen biodegradable microparticles formed using water-in-oil-in-water (W/O/W) double emulsion method, as a neurotrophic factor delivery vehicle. The microparticles were encapsulated with glial cell-derived neurotrophic factor (GDNF) fused with collagen binding peptide (CBP) immobilized to the inner collagen phase. The novelty lies in the strict regulation of release of GDNF-CBP from the microparticles as compared to a burst release from standard microparticles. The microparticles were demonstrated to be non-cytotoxic till 300 μg/2 × 10⁵ cells and revealed a maximum release of 250 ng GDNF-CBP/mg microparticles in 0.3% collagenase. Differentiation of neural progenitor cells (NPCs) into mature neurons was demonstrated by co-culturing microparticles with cells in a medium containing collagenase which enabled the release of encapsulated GDNF-CBP, signaling the differentiation of NPCs into microtubule-associated protein 2 (MAP2)-expressing neurons. The successful ability of these microparticles to deliver neurotrophic factors and allow differentiation of NPCs into mature neurons provides some scope in its use for the treatment of Parkinson's disease and other neurodegenerative diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PLGA/collagen MS may be used to deliver GDNF, and in vitro application stimulates differentiation of neuronal progenitor cells into mature neurons.
“Gujral et al. also showed that PLGA/collagen MS may be used to deliver GDNF, and in vitro application suggests that it stimulates the differentiation of neuronal progenitor cells into mature neurons.131”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [131]
The citation lists haven’t been fetched yet
References 48 · Cited by 21
- Authors
- Gujral, C., Minagawa, Y., Fujimoto, K., Kitano, H., & Nakaji-Hirabayashi, T.
- Affiliations
- University of Toyama (JP)
- Corresponding author
- Kitano, H.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 168
- Issue
- 3
- Pages
- 307-316
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2065524355
- Cited by
- 21
- References
- 48
- Citations by year
- 2025: 1 · 2024: 2 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 6 · 2014: 1 · 2013: 1
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Toyama
- Japan Society for the Promotion of Science (22350101, 22700468)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- biodegradable microparticles, neurotrophic factor delivery, glial cell line-derived neurotrophic factor, collagen-binding peptide, water-in-oil-in-water emulsion, controlled release, burst release, neural progenitor cells, neuronal differentiation, Parkinson's disease, neurodegenerative diseases, collagenase
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Cell Differentiation, Cell Survival, Cells, Cultured, Collagen, Humans, Neurons, Peptide Fragments, Polyglycolic Acid, Recombinant Proteins, Sialoglycoproteins, Lactic Acid, Glial Cell Line-Derived Neurotrophic Factor, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review